Atomistry » Zinc » PDB 1rqf-1sda » 1rtl
Atomistry »
  Zinc »
    PDB 1rqf-1sda »
      1rtl »

Zinc in PDB 1rtl: Crystal Structure of Hcv NS3 Protease Domain: NS4A Peptide Complex with Covalently Bound Pyrrolidine-5,5-Translactam Inhibitor

Protein crystallography data

The structure of Crystal Structure of Hcv NS3 Protease Domain: NS4A Peptide Complex with Covalently Bound Pyrrolidine-5,5-Translactam Inhibitor, PDB code: 1rtl was solved by T.Skarzynski, D.O.N.Somers, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 20.00 / 2.75
Space group H 3 2
Cell size a, b, c (Å), α, β, γ (°) 224.082, 224.082, 75.694, 90.00, 90.00, 120.00
R / Rfree (%) 18 / 23.4

Zinc Binding Sites:

The binding sites of Zinc atom in the Crystal Structure of Hcv NS3 Protease Domain: NS4A Peptide Complex with Covalently Bound Pyrrolidine-5,5-Translactam Inhibitor (pdb code 1rtl). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the Crystal Structure of Hcv NS3 Protease Domain: NS4A Peptide Complex with Covalently Bound Pyrrolidine-5,5-Translactam Inhibitor, PDB code: 1rtl:
Jump to Zinc binding site number: 1; 2;

Zinc binding site 1 out of 2 in 1rtl

Go back to Zinc Binding Sites List in 1rtl
Zinc binding site 1 out of 2 in the Crystal Structure of Hcv NS3 Protease Domain: NS4A Peptide Complex with Covalently Bound Pyrrolidine-5,5-Translactam Inhibitor


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Crystal Structure of Hcv NS3 Protease Domain: NS4A Peptide Complex with Covalently Bound Pyrrolidine-5,5-Translactam Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn301

b:56.3
occ:1.00
O A:HOH307 2.2 24.0 1.0
SG A:CYS97 2.3 51.0 1.0
SG A:CYS99 2.4 58.9 1.0
SG A:CYS145 2.4 49.8 1.0
CB A:CYS145 3.3 46.0 1.0
CB A:CYS99 3.3 59.8 1.0
CB A:CYS97 3.4 55.6 1.0
N A:CYS99 3.4 61.4 1.0
N A:THR98 3.7 59.4 1.0
CA A:CYS97 3.7 54.6 1.0
CA A:CYS99 3.9 60.0 1.0
C A:CYS97 4.2 56.2 1.0
CB A:HIS149 4.2 44.0 1.0
ND1 A:HIS149 4.4 65.8 1.0
C A:THR98 4.5 63.3 1.0
CB A:ALA147 4.7 41.3 1.0
CG A:HIS149 4.7 53.1 1.0
C A:CYS99 4.7 59.1 1.0
CA A:THR98 4.7 61.1 1.0
CA A:CYS145 4.8 45.8 1.0
N A:GLY100 4.8 57.6 1.0

Zinc binding site 2 out of 2 in 1rtl

Go back to Zinc Binding Sites List in 1rtl
Zinc binding site 2 out of 2 in the Crystal Structure of Hcv NS3 Protease Domain: NS4A Peptide Complex with Covalently Bound Pyrrolidine-5,5-Translactam Inhibitor


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 2 of Crystal Structure of Hcv NS3 Protease Domain: NS4A Peptide Complex with Covalently Bound Pyrrolidine-5,5-Translactam Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Zn301

b:43.8
occ:1.00
SG B:CYS145 2.3 39.5 1.0
SG B:CYS99 2.3 49.5 1.0
O B:HOH305 2.3 7.5 1.0
SG B:CYS97 2.3 39.2 1.0
CB B:CYS145 3.3 33.9 1.0
CB B:CYS99 3.4 52.2 1.0
CB B:CYS97 3.4 47.1 1.0
N B:CYS99 3.4 54.7 1.0
CA B:CYS97 3.8 47.2 1.0
N B:THR98 3.8 47.4 1.0
CA B:CYS99 3.9 53.9 1.0
C B:CYS97 4.2 46.9 1.0
CB B:HIS149 4.2 39.5 1.0
CB B:ALA147 4.4 42.9 1.0
C B:THR98 4.5 53.3 1.0
CA B:CYS145 4.7 33.8 1.0
C B:CYS99 4.7 54.5 1.0
N B:ALA147 4.8 41.8 1.0
CA B:THR98 4.8 49.6 1.0
CG B:HIS149 4.8 35.5 1.0
N B:GLY100 4.9 54.4 1.0
ND1 B:HIS149 4.9 44.5 1.0
OH A:TYR105 4.9 55.7 1.0
CD B:PRO146 4.9 40.2 1.0
CE2 A:TYR105 5.0 54.0 1.0

Reference:

M.J.Slater, E.M.Amphlett, D.M.Andrews, P.Bamborough, S.J.Carey, M.R.Johnson, P.S.Jones, G.Mills, N.R.Parry, D.O.Somers, A.J.Stewart, T.Skarzynski. Pyrrolidine-5,5-Trans-Lactams. 4. Incorporation of A P3/P4 Urea Leads to Potent Intracellular Inhibitors of Hepatitis C Virus NS3/4A Protease Org.Lett. V. 5 4627 2003.
ISSN: ISSN 1523-7060
PubMed: 14627400
DOI: 10.1021/OL035826V
Page generated: Mon Jan 25 16:13:03 2021

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy